Literature DB >> 9554461

Phase I study of taxol in refractory acute myelogenous leukemias using a weekly schedule.

R Munker1, H Kantarjian, S O'Brien, M Keating, M Andreeff, E H Estey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9554461     DOI： 10.1159/000040822

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  2 in total

1.  A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study.

Authors:  Terzah M Horton; Matthew M Ames; Joel M Reid; Mark D Krailo; Thomas Pendergrass; Revonda Mosher; Gregory H Reaman; Nita L Seibel
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

2.  Phase II study of single agent paclitaxel in adult patients with relapsed acute lymphocytic leukemia.

Authors:  Dawn E Colburn; Deborah A Thomas; Francis J Giles
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.